| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |